07:00 , Oct 21, 2013 |  BC Week In Review  |  Financial News

Chimerix financial update

Chimerix said shareholders sold 2.5 million shares at $16.50 in a secondary offering underwritten by Morgan Stanley and Cowen. Participating shareholders include New Leaf Ventures; Canaan Partners; and Alta Biopharma Partners. Earlier this month, the...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Financial News

Chimerix financial update

Chimerix shareholders proposed to sell up to $50 million in shares in a secondary offering underwritten by Morgan Stanley and Cowen. Participating shareholders include Sanderling Venture Partners; New Leaf Ventures; Canaan Partners; and Alta Biopharma...
07:00 , Jul 26, 2010 |  BC Week In Review  |  Financial News

Cara completes venture financing

Cara Therapeutics Inc. , Shelton, Conn.   Business: Neurology   Date completed: 7/21/10   Type: Venture financing   Raised: $15 million   Investors: Rho Ventures; Alta Biopharma; Ascent Biomedical Ventures; Connecticut Innovations; Devon Park Bioventures;...
00:35 , Jul 22, 2010 |  BC Extra  |  Financial News

Cara raises $15 million

Cara Therapeutics Inc. (Shelton, Conn.) raised $15 million in a series D round led by new investor Rho Ventures. Existing investors Alta Biopharma; Ascent Biomedical Ventures; Connecticut Innovations; Devon Park Bioventures; Healthcare Private Equity; Mitsubishi...
07:00 , Sep 3, 2007 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Cara Therapeutics Inc. Shelton, Conn. Technology: Kappa opioid receptor agonists and GPCR DimerScreen technology Disease focus: Neurology, inflammation Clinical status: Phase IIa Founded: 2004 by Derek Chalmers, Frederique Menzaghi and Michael Lewis University collaborators: None...
08:00 , Dec 4, 2006 |  BC Week In Review  |  Company News

Cara board of directors update

Cara Therapeutics Inc. , Tarrytown, N.Y.   Business: Neurology   Appointed: Stephen Reeders, managing partner of MVM Life Science Partners; and Ed Hurwitz, director of Alta Biopharma Partners  ...
07:00 , May 17, 2004 |  BioCentury  |  Finance

Fresh capital

Fresh capital...
07:00 , Apr 12, 2004 |  BioCentury  |  Finance

Ebb & Flow

IPO windows tend to stay open only so long as investors can see some upside from offering prices. Thus neurology company...
07:00 , Apr 5, 2004 |  BioCentury  |  Finance

Ebb & Flow

Private investors continued their love affair with the life sciences, as Alta Partners raised $475 million for two funds last week, and - in a slight change of direction - all of the money will...
08:00 , Mar 30, 2004 |  BC Extra  |  Financial News

Alta raises $475 million

Alta Partners raised $475 million for two of its life science funds: Alta BioPharma Partners III and ACP IV. The funds will invest in later-stage biotech and medical device companies. Similar to its earlier funds,...